CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 139 filers reported holding CARA THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.93 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $370,000 | +63.0% | 17,200 | +48.8% | 0.00% | 0.0% |
| Q1 2019 | $227,000 | -90.9% | 11,562 | -88.9% | 0.00% | -87.5% |
| Q3 2018 | $2,488,000 | +406.7% | 103,900 | +159.1% | 0.02% | +700.0% |
| Q4 2017 | $491,000 | -71.4% | 40,100 | -68.0% | 0.00% | -83.3% |
| Q3 2017 | $1,714,000 | +48.5% | 125,200 | +66.9% | 0.01% | +50.0% |
| Q2 2017 | $1,154,000 | – | 75,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RHO CAPITAL PARTNERS INC | 2,799,058 | $42,350,000 | 22.29% |
| Chescapmanager LLC | 1,314,603 | $19,890,000 | 2.42% |
| Prosight Management, LP | 294,041 | $4,449,000 | 2.06% |
| DAFNA Capital Management LLC | 261,442 | $3,956,000 | 1.18% |
| Cypress Capital Management LLC (WY) | 81,269 | $1,230,000 | 1.06% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 626,583 | $9,480,000 | 1.02% |
| Carmignac Gestion | 1,851,443 | $28,012,000 | 0.29% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,465,000 | $37,295,000 | 0.22% |
| Ikarian Capital, LLC | 301,700 | $4,565,000 | 0.20% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 689,899 | $10,438,000 | 0.20% |